To confirm that BH4-dependent interactions between KRAS and BCL-XL account for its effect on RAS signalling, we used a BRET-based RAS activity sensor in epithelial human breast cancer MCF-7 cells stably overexpressing equivalent levels of wild type or BH4-deleted BCL-XL. This evidence concerns the gene BCL2L1 and breast cancer.